ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Urea Cycle Disorders Treatment Drug Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-20G14329
Home | Market Reports | Health| Nursing
Global Urea Cycle Disorders Treatment Drug Market Research Report 2023
BUY CHAPTERS

Global Urea Cycle Disorders Treatment Drug Market Research Report 2025

Code: QYRE-Auto-20G14329
Report
April 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Horizon Therapeutics plc
Bausch Health Companies Inc.
Recordati Rare Diseases Inc.
Nestle S A
Danone
Lucane Pharma SA
Acer Therapeutics Inc.
Ultragenyx Pharmaceutical
Arcturus Therapeutics Holdings Inc.
Orpharma
Selecta Biosciences Inc
Abbott
Mead Johnson & Company, LLC
Aeglea Biotherapeutics, Inc

Urea Cycle Disorders Treatment Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Urea Cycle Disorders Treatment Drug Market

Urea Cycle Disorders Treatment Drug Market

The global market for Urea Cycle Disorders Treatment Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Urea Cycle Disorders Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urea Cycle Disorders Treatment Drug.
The Urea Cycle Disorders Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Urea Cycle Disorders Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urea Cycle Disorders Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Urea Cycle Disorders Treatment Drug Market Report

Report Metric Details
Report Name Urea Cycle Disorders Treatment Drug Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Horizon Therapeutics Plc, Bausch Health Companies Inc., Recordati Rare Diseases Inc., Nestle S.A., Danone S.A., Lucane Pharma SA, Acer Therapeutics Inc., Ultragenyx Pharmaceutical, Aeglea Biotherapeutics, Inc, Arcturus Therapeutics Holdings Inc., Orpharma Pty Ltd., Selecta Biosciences, Inc., Abbott, Mead Johnson & Company, LLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Urea Cycle Disorders Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Urea Cycle Disorders Treatment Drug Market report?

Ans: The main players in the Urea Cycle Disorders Treatment Drug Market are Horizon Therapeutics Plc, Bausch Health Companies Inc., Recordati Rare Diseases Inc., Nestle S.A., Danone S.A., Lucane Pharma SA, Acer Therapeutics Inc., Ultragenyx Pharmaceutical, Aeglea Biotherapeutics, Inc, Arcturus Therapeutics Holdings Inc., Orpharma Pty Ltd., Selecta Biosciences, Inc., Abbott, Mead Johnson & Company, LLC

What are the Application segmentation covered in the Urea Cycle Disorders Treatment Drug Market report?

Ans: The Applications covered in the Urea Cycle Disorders Treatment Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Urea Cycle Disorders Treatment Drug Market report?

Ans: The Types covered in the Urea Cycle Disorders Treatment Drug Market report are Amino Acid Supplements, Sodium Phenylbutyrate, Glycerol Phenylbutyrate, Sodium Benzoate, Others

Recommended Reports

Rare and Genetic Disorders

Urinary and Kidney Health

Chronic and Metabolic Disorders

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Amino Acid Supplements
1.2.3 Sodium Phenylbutyrate
1.2.4 Glycerol Phenylbutyrate
1.2.5 Sodium Benzoate
1.2.6 Others
1.3 Market by Application
1.3.1 Global Urea Cycle Disorders Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Urea Cycle Disorders Treatment Drug Market Perspective (2020-2031)
2.2 Global Urea Cycle Disorders Treatment Drug Growth Trends by Region
2.2.1 Global Urea Cycle Disorders Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Urea Cycle Disorders Treatment Drug Historic Market Size by Region (2020-2025)
2.2.3 Urea Cycle Disorders Treatment Drug Forecasted Market Size by Region (2026-2031)
2.3 Urea Cycle Disorders Treatment Drug Market Dynamics
2.3.1 Urea Cycle Disorders Treatment Drug Industry Trends
2.3.2 Urea Cycle Disorders Treatment Drug Market Drivers
2.3.3 Urea Cycle Disorders Treatment Drug Market Challenges
2.3.4 Urea Cycle Disorders Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urea Cycle Disorders Treatment Drug Players by Revenue
3.1.1 Global Top Urea Cycle Disorders Treatment Drug Players by Revenue (2020-2025)
3.1.2 Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Players (2020-2025)
3.2 Global Urea Cycle Disorders Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Urea Cycle Disorders Treatment Drug Revenue
3.4 Global Urea Cycle Disorders Treatment Drug Market Concentration Ratio
3.4.1 Global Urea Cycle Disorders Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urea Cycle Disorders Treatment Drug Revenue in 2024
3.5 Global Key Players of Urea Cycle Disorders Treatment Drug Head office and Area Served
3.6 Global Key Players of Urea Cycle Disorders Treatment Drug, Product and Application
3.7 Global Key Players of Urea Cycle Disorders Treatment Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Urea Cycle Disorders Treatment Drug Breakdown Data by Type
4.1 Global Urea Cycle Disorders Treatment Drug Historic Market Size by Type (2020-2025)
4.2 Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Type (2026-2031)
5 Urea Cycle Disorders Treatment Drug Breakdown Data by Application
5.1 Global Urea Cycle Disorders Treatment Drug Historic Market Size by Application (2020-2025)
5.2 Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
6.2 North America Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025)
6.4 North America Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
7.2 Europe Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025)
7.4 Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
8.2 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
9.2 Latin America Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025)
9.4 Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
10.2 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Horizon Therapeutics Plc
11.1.1 Horizon Therapeutics Plc Company Details
11.1.2 Horizon Therapeutics Plc Business Overview
11.1.3 Horizon Therapeutics Plc Urea Cycle Disorders Treatment Drug Introduction
11.1.4 Horizon Therapeutics Plc Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.1.5 Horizon Therapeutics Plc Recent Development
11.2 Bausch Health Companies Inc.
11.2.1 Bausch Health Companies Inc. Company Details
11.2.2 Bausch Health Companies Inc. Business Overview
11.2.3 Bausch Health Companies Inc. Urea Cycle Disorders Treatment Drug Introduction
11.2.4 Bausch Health Companies Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.2.5 Bausch Health Companies Inc. Recent Development
11.3 Recordati Rare Diseases Inc.
11.3.1 Recordati Rare Diseases Inc. Company Details
11.3.2 Recordati Rare Diseases Inc. Business Overview
11.3.3 Recordati Rare Diseases Inc. Urea Cycle Disorders Treatment Drug Introduction
11.3.4 Recordati Rare Diseases Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.3.5 Recordati Rare Diseases Inc. Recent Development
11.4 Nestle S.A.
11.4.1 Nestle S.A. Company Details
11.4.2 Nestle S.A. Business Overview
11.4.3 Nestle S.A. Urea Cycle Disorders Treatment Drug Introduction
11.4.4 Nestle S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.4.5 Nestle S.A. Recent Development
11.5 Danone S.A.
11.5.1 Danone S.A. Company Details
11.5.2 Danone S.A. Business Overview
11.5.3 Danone S.A. Urea Cycle Disorders Treatment Drug Introduction
11.5.4 Danone S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.5.5 Danone S.A. Recent Development
11.6 Lucane Pharma SA
11.6.1 Lucane Pharma SA Company Details
11.6.2 Lucane Pharma SA Business Overview
11.6.3 Lucane Pharma SA Urea Cycle Disorders Treatment Drug Introduction
11.6.4 Lucane Pharma SA Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.6.5 Lucane Pharma SA Recent Development
11.7 Acer Therapeutics Inc.
11.7.1 Acer Therapeutics Inc. Company Details
11.7.2 Acer Therapeutics Inc. Business Overview
11.7.3 Acer Therapeutics Inc. Urea Cycle Disorders Treatment Drug Introduction
11.7.4 Acer Therapeutics Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.7.5 Acer Therapeutics Inc. Recent Development
11.8 Ultragenyx Pharmaceutical
11.8.1 Ultragenyx Pharmaceutical Company Details
11.8.2 Ultragenyx Pharmaceutical Business Overview
11.8.3 Ultragenyx Pharmaceutical Urea Cycle Disorders Treatment Drug Introduction
11.8.4 Ultragenyx Pharmaceutical Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.8.5 Ultragenyx Pharmaceutical Recent Development
11.9 Aeglea Biotherapeutics, Inc
11.9.1 Aeglea Biotherapeutics, Inc Company Details
11.9.2 Aeglea Biotherapeutics, Inc Business Overview
11.9.3 Aeglea Biotherapeutics, Inc Urea Cycle Disorders Treatment Drug Introduction
11.9.4 Aeglea Biotherapeutics, Inc Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.9.5 Aeglea Biotherapeutics, Inc Recent Development
11.10 Arcturus Therapeutics Holdings Inc.
11.10.1 Arcturus Therapeutics Holdings Inc. Company Details
11.10.2 Arcturus Therapeutics Holdings Inc. Business Overview
11.10.3 Arcturus Therapeutics Holdings Inc. Urea Cycle Disorders Treatment Drug Introduction
11.10.4 Arcturus Therapeutics Holdings Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.10.5 Arcturus Therapeutics Holdings Inc. Recent Development
11.11 Orpharma Pty Ltd.
11.11.1 Orpharma Pty Ltd. Company Details
11.11.2 Orpharma Pty Ltd. Business Overview
11.11.3 Orpharma Pty Ltd. Urea Cycle Disorders Treatment Drug Introduction
11.11.4 Orpharma Pty Ltd. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.11.5 Orpharma Pty Ltd. Recent Development
11.12 Selecta Biosciences, Inc.
11.12.1 Selecta Biosciences, Inc. Company Details
11.12.2 Selecta Biosciences, Inc. Business Overview
11.12.3 Selecta Biosciences, Inc. Urea Cycle Disorders Treatment Drug Introduction
11.12.4 Selecta Biosciences, Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.12.5 Selecta Biosciences, Inc. Recent Development
11.13 Abbott
11.13.1 Abbott Company Details
11.13.2 Abbott Business Overview
11.13.3 Abbott Urea Cycle Disorders Treatment Drug Introduction
11.13.4 Abbott Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.13.5 Abbott Recent Development
11.14 Mead Johnson & Company, LLC
11.14.1 Mead Johnson & Company, LLC Company Details
11.14.2 Mead Johnson & Company, LLC Business Overview
11.14.3 Mead Johnson & Company, LLC Urea Cycle Disorders Treatment Drug Introduction
11.14.4 Mead Johnson & Company, LLC Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.14.5 Mead Johnson & Company, LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Horizon Therapeutics plc
Bausch Health Companies Inc.
Recordati Rare Diseases Inc.
Nestle S A
Danone
Lucane Pharma SA
Acer Therapeutics Inc.
Ultragenyx Pharmaceutical
Arcturus Therapeutics Holdings Inc.
Orpharma
Selecta Biosciences Inc
Abbott
Mead Johnson & Company, LLC
Aeglea Biotherapeutics, Inc
List of Tables
 Table 1. Global Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Amino Acid Supplements
 Table 3. Key Players of Sodium Phenylbutyrate
 Table 4. Key Players of Glycerol Phenylbutyrate
 Table 5. Key Players of Sodium Benzoate
 Table 6. Key Players of Others
 Table 7. Global Urea Cycle Disorders Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Urea Cycle Disorders Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Urea Cycle Disorders Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Urea Cycle Disorders Treatment Drug Market Share by Region (2020-2025)
 Table 11. Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Urea Cycle Disorders Treatment Drug Market Share by Region (2026-2031)
 Table 13. Urea Cycle Disorders Treatment Drug Market Trends
 Table 14. Urea Cycle Disorders Treatment Drug Market Drivers
 Table 15. Urea Cycle Disorders Treatment Drug Market Challenges
 Table 16. Urea Cycle Disorders Treatment Drug Market Restraints
 Table 17. Global Urea Cycle Disorders Treatment Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Urea Cycle Disorders Treatment Drug Market Share by Players (2020-2025)
 Table 19. Global Top Urea Cycle Disorders Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urea Cycle Disorders Treatment Drug as of 2024)
 Table 20. Ranking of Global Top Urea Cycle Disorders Treatment Drug Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Urea Cycle Disorders Treatment Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Urea Cycle Disorders Treatment Drug, Headquarters and Area Served
 Table 23. Global Key Players of Urea Cycle Disorders Treatment Drug, Product and Application
 Table 24. Global Key Players of Urea Cycle Disorders Treatment Drug, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Urea Cycle Disorders Treatment Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Type (2020-2025)
 Table 28. Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Type (2026-2031)
 Table 30. Global Urea Cycle Disorders Treatment Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Application (2020-2025)
 Table 32. Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Application (2026-2031)
 Table 34. North America Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Horizon Therapeutics Plc Company Details
 Table 50. Horizon Therapeutics Plc Business Overview
 Table 51. Horizon Therapeutics Plc Urea Cycle Disorders Treatment Drug Product
 Table 52. Horizon Therapeutics Plc Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
 Table 53. Horizon Therapeutics Plc Recent Development
 Table 54. Bausch Health Companies Inc. Company Details
 Table 55. Bausch Health Companies Inc. Business Overview
 Table 56. Bausch Health Companies Inc. Urea Cycle Disorders Treatment Drug Product
 Table 57. Bausch Health Companies Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
 Table 58. Bausch Health Companies Inc. Recent Development
 Table 59. Recordati Rare Diseases Inc. Company Details
 Table 60. Recordati Rare Diseases Inc. Business Overview
 Table 61. Recordati Rare Diseases Inc. Urea Cycle Disorders Treatment Drug Product
 Table 62. Recordati Rare Diseases Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
 Table 63. Recordati Rare Diseases Inc. Recent Development
 Table 64. Nestle S.A. Company Details
 Table 65. Nestle S.A. Business Overview
 Table 66. Nestle S.A. Urea Cycle Disorders Treatment Drug Product
 Table 67. Nestle S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
 Table 68. Nestle S.A. Recent Development
 Table 69. Danone S.A. Company Details
 Table 70. Danone S.A. Business Overview
 Table 71. Danone S.A. Urea Cycle Disorders Treatment Drug Product
 Table 72. Danone S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
 Table 73. Danone S.A. Recent Development
 Table 74. Lucane Pharma SA Company Details
 Table 75. Lucane Pharma SA Business Overview
 Table 76. Lucane Pharma SA Urea Cycle Disorders Treatment Drug Product
 Table 77. Lucane Pharma SA Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
 Table 78. Lucane Pharma SA Recent Development
 Table 79. Acer Therapeutics Inc. Company Details
 Table 80. Acer Therapeutics Inc. Business Overview
 Table 81. Acer Therapeutics Inc. Urea Cycle Disorders Treatment Drug Product
 Table 82. Acer Therapeutics Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
 Table 83. Acer Therapeutics Inc. Recent Development
 Table 84. Ultragenyx Pharmaceutical Company Details
 Table 85. Ultragenyx Pharmaceutical Business Overview
 Table 86. Ultragenyx Pharmaceutical Urea Cycle Disorders Treatment Drug Product
 Table 87. Ultragenyx Pharmaceutical Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
 Table 88. Ultragenyx Pharmaceutical Recent Development
 Table 89. Aeglea Biotherapeutics, Inc Company Details
 Table 90. Aeglea Biotherapeutics, Inc Business Overview
 Table 91. Aeglea Biotherapeutics, Inc Urea Cycle Disorders Treatment Drug Product
 Table 92. Aeglea Biotherapeutics, Inc Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
 Table 93. Aeglea Biotherapeutics, Inc Recent Development
 Table 94. Arcturus Therapeutics Holdings Inc. Company Details
 Table 95. Arcturus Therapeutics Holdings Inc. Business Overview
 Table 96. Arcturus Therapeutics Holdings Inc. Urea Cycle Disorders Treatment Drug Product
 Table 97. Arcturus Therapeutics Holdings Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
 Table 98. Arcturus Therapeutics Holdings Inc. Recent Development
 Table 99. Orpharma Pty Ltd. Company Details
 Table 100. Orpharma Pty Ltd. Business Overview
 Table 101. Orpharma Pty Ltd. Urea Cycle Disorders Treatment Drug Product
 Table 102. Orpharma Pty Ltd. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
 Table 103. Orpharma Pty Ltd. Recent Development
 Table 104. Selecta Biosciences, Inc. Company Details
 Table 105. Selecta Biosciences, Inc. Business Overview
 Table 106. Selecta Biosciences, Inc. Urea Cycle Disorders Treatment Drug Product
 Table 107. Selecta Biosciences, Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
 Table 108. Selecta Biosciences, Inc. Recent Development
 Table 109. Abbott Company Details
 Table 110. Abbott Business Overview
 Table 111. Abbott Urea Cycle Disorders Treatment Drug Product
 Table 112. Abbott Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
 Table 113. Abbott Recent Development
 Table 114. Mead Johnson & Company, LLC Company Details
 Table 115. Mead Johnson & Company, LLC Business Overview
 Table 116. Mead Johnson & Company, LLC Urea Cycle Disorders Treatment Drug Product
 Table 117. Mead Johnson & Company, LLC Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
 Table 118. Mead Johnson & Company, LLC Recent Development
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources
 Table 122. Authors List of This Report


List of Figures
 Figure 1. Urea Cycle Disorders Treatment Drug Picture
 Figure 2. Global Urea Cycle Disorders Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Urea Cycle Disorders Treatment Drug Market Share by Type: 2024 VS 2031
 Figure 4. Amino Acid Supplements Features
 Figure 5. Sodium Phenylbutyrate Features
 Figure 6. Glycerol Phenylbutyrate Features
 Figure 7. Sodium Benzoate Features
 Figure 8. Others Features
 Figure 9. Global Urea Cycle Disorders Treatment Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Urea Cycle Disorders Treatment Drug Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Case Studies
 Figure 12. Clinic Case Studies
 Figure 13. Others Case Studies
 Figure 14. Urea Cycle Disorders Treatment Drug Report Years Considered
 Figure 15. Global Urea Cycle Disorders Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Urea Cycle Disorders Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Urea Cycle Disorders Treatment Drug Market Share by Region: 2024 VS 2031
 Figure 18. Global Urea Cycle Disorders Treatment Drug Market Share by Players in 2024
 Figure 19. Global Top Urea Cycle Disorders Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urea Cycle Disorders Treatment Drug as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Urea Cycle Disorders Treatment Drug Revenue in 2024
 Figure 21. North America Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Urea Cycle Disorders Treatment Drug Market Share by Country (2020-2031)
 Figure 23. United States Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Urea Cycle Disorders Treatment Drug Market Share by Country (2020-2031)
 Figure 27. Germany Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Share by Region (2020-2031)
 Figure 35. China Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Urea Cycle Disorders Treatment Drug Market Share by Country (2020-2031)
 Figure 43. Mexico Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Share by Country (2020-2031)
 Figure 47. Turkey Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Horizon Therapeutics Plc Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
 Figure 51. Bausch Health Companies Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
 Figure 52. Recordati Rare Diseases Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
 Figure 53. Nestle S.A. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
 Figure 54. Danone S.A. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
 Figure 55. Lucane Pharma SA Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
 Figure 56. Acer Therapeutics Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
 Figure 57. Ultragenyx Pharmaceutical Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
 Figure 58. Aeglea Biotherapeutics, Inc Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
 Figure 59. Arcturus Therapeutics Holdings Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
 Figure 60. Orpharma Pty Ltd. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
 Figure 61. Selecta Biosciences, Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
 Figure 62. Abbott Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
 Figure 63. Mead Johnson & Company, LLC Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Drugs to Treat Urea Cycle Disorders Market Research Report 2024
Amino Acid Metabolism Disorder Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Disease Treatment Market Research Report 2024
Clinical Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Shrimp s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cowden Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neurologic Disorder Treatment Drug Market Research Report 2024
Urinary System Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Genitourinary System Treatment Market Research Report 2024
Respiratory Disorders Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Assisted Reproductive Technology Drugs Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Wilsons Disease Treatment Market Research Report 2024
Hyperammonemia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Treating Mental Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Urinary Incontinence Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bleeding Disorder Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rare Kidney Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Life Sciences IT Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-19E17259
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Rehabilitation Evaluation Equipment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39U17029
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Modular Healthcare Buildings Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-24Y16719
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Digital Telepathology Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0S20450
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions